<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In a search for genes specifically expressed in Reed-Sternberg (RS) cells of Hodgkin <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e>), we applied the serial analysis of gene expression (SAGE) technique on the <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e>-derived cell line DEV </plain></SENT>
<SENT sid="1" pm="."><plain>Genes highly expressed in DEV were subjected to an RT-PCR analysis to confirm the SAGE results </plain></SENT>
<SENT sid="2" pm="."><plain>For one of the genes, a high expression was observed in DEV and other <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e>-derived cell lines but not in non-Hodgkin <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (NHL)-derived cell lines and <z:mpath ids='MPATH_458'>normal</z:mpath> controls, suggesting an <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e>-specific expression </plain></SENT>
<SENT sid="3" pm="."><plain>This gene corresponds to the human BIC gene, a member of the noncoding <z:chebi fb="2" ids="33699">mRNA</z:chebi>-like molecules </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="40" ids="33697">RNA</z:chebi> in situ hybridization (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ISH</z:e>) indicated an exclusive nucleolar localization of BIC transcripts in <z:hpo ids='HP_0000001'>all</z:hpo> RS cells in 91% of <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e> cases, including nodular lymphocyte predominance (NLP) <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e> and classical <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Analyses of <z:mpath ids='MPATH_458'>normal</z:mpath> human tissues revealed BIC transcripts in only a small number of CD20-positive B-cells in lymph node and tonsil tissue, albeit at a much lower level compared to that of RS cells </plain></SENT>
<SENT sid="6" pm="."><plain>BIC RT-PCR in the Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo>-derived cell line Ramos demonstrated a significant up-regulation upon cross-linking of the B-cell receptor (BcR) </plain></SENT>
<SENT sid="7" pm="."><plain>IkappaBalpha-mediated blocking of NF-kappaB translocation in Ramos did not effect the up-regulation of BIC expression upon BcR triggering, suggesting that activation of NF-kappaB is not involved in regulation of BIC expression </plain></SENT>
<SENT sid="8" pm="."><plain>In summary, our data show that expression of BIC is specific for RS cells of <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>In <z:mpath ids='MPATH_458'>normal</z:mpath> tissue, BIC is expressed weakly in a minority of germinal center B cells </plain></SENT>
<SENT sid="10" pm="."><plain>Expression of BIC can be modified/influenced by BcR triggering, indicating that BIC might play a role in the selection of B cells </plain></SENT>
</text></document>